3rd Edition of Infectious Diseases World Conference (IDWC 2026)
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 3rd Edition of Infectious Diseases World Conference (IDWC 2026) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
3rd Edition of Infectious Diseases World Conference (IDWC 2026)
Date: November 15–18, 2026
Venue: Dubai International Convention & Exhibition Centre, Dubai, UAE
Event Type: Medical Research, Public Health, Clinical Practice, Epidemiology, Vaccine Development, Antimicrobial Resistance
Estimated Attendance: 4,500+ global delegates including researchers, clinicians, public health officials, policymakers, pharmaceutical executives, and medical educators.
1️⃣ Who Attends (BUYERS / ATTENDEES)
- Chief Medical Officers and Clinical Directors from hospitals and healthcare systems
- Public Health Directors and Epidemiologists from government agencies
- Research Scientists and Virologists from academic institutions
- Procurement Managers for medical equipment and diagnostic tools
- Pharmaceutical and Biotech Executives (R&D, Business Development, Regulatory Affairs)
- Global Health Organizations (WHO, CDC, MSF representatives)
- Medical Educators and Training Program Directors
- Investors and Venture Capital firms in health tech and biopharma
2️⃣ Location + Attendee Geographic Origin
Show Location: Dubai International Convention & Exhibition Centre, Dubai, UAE
Attendee Origin: Global audience with strong representation from:
- Middle East & North Africa (35%): Government health officials, hospital networks
- Europe (25%): Researchers, pharmaceutical companies, public health institutions
- Asia-Pacific (20%): Clinical practitioners, medical device distributors
- Africa (10%): NGO representatives, disease surveillance teams
- Americas (10%): Academic medical centers, CDC-aligned organizations
3️⃣ Audience Reach
Reach Type: Global with regional implementation focus. Combines cutting-edge research presentations with policy discussions and procurement opportunities for healthcare systems.
4️⃣ Sample Buyer Company Names + Websites
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Gilead Sciences | https://www.gilead.com | Director, Antiviral Research | Key player in hepatitis, HIV, and emerging pathogen therapeutics |
| 2 | BD (Becton, Dickinson and Company) | https://www.bdgeneius.com | Sr. Product Manager, Diagnostic Systems | Major supplier of infection control and diagnostic equipment |
| 3 | King Abdulaziz University Hospital | https://www.kau.edu.sa | Chief of Infectious Diseases | Leading Middle Eastern healthcare institution with procurement power |
| 4 | Sanofi Pasteur | https://www.sanofipasteur.com | Head of Vaccine Development | Global vaccine manufacturer with R&D and procurement needs |
| 5 | Sequencing.com | https://www.sequencing.com | CEO / Business Development Director | Genomic sequencing services for pathogen tracking and research |
5️⃣ Job Profiles, Industries & Event Type
Best Job Profiles to Target:
- Chief Medical Officer
- Director of Clinical Research
- Global Health Security Advisor
- Procurement Director, Medical Supplies
- Vice President, R&D (Biopharma)
- Medical Device Sales Director
- Public Health Emergency Manager
Key Industries: Pharmaceuticals, Biotechnology, Hospitals & Clinics, Medical Device Manufacturing, Public Health Administration, Diagnostic Laboratories, Academic Research Institutions
6️⃣ Estimated Attendance
4,500+ registered delegates including:
- 1,200+ researchers and clinicians presenting studies
- 800+ healthcare procurement officials
- 650+ pharmaceutical and biotech executives
- 300+ government and NGO representatives
- 200+ exhibiting companies
7️⃣ Key Focus Areas & Buyer Engagement
Core Themes:
- Emerging infectious disease threats (COVID-19, MERS, Dengue)
- Antimicrobial resistance and stewardship
- Vaccine development and distribution equity
- Digital health tools for outbreak tracking
- Point-of-care diagnostic innovations
- Hospital infection control protocols
Engagement Angle: Position your solution as either a research collaboration partner, procurement-ready medical technology, or capacity-building tool for healthcare systems in emerging markets.
8️⃣ Client-Product Fit Note
Please share your client's website to refine targeting. For example:
- If selling diagnostic equipment: Prioritize BD, Qiagen, and hospital procurement teams
- If offering AI-driven outbreak prediction: Target WHO advisors and public health agencies
- If developing antiviral therapies: Focus on Gilead, Sanofi, and academic research leads
9️⃣ Final Recommendation
Quality Rating for B2B Engagement: 9/10
IDWC 2026 offers unparalleled access to decision-makers addressing infectious diseases across clinical, research, and policy domains. Particularly valuable for companies seeking:
- Global health partnerships in emerging markets
- Clinical trial collaborations
- Procurement contracts with multinational healthcare systems
- Thought leadership opportunities in vaccine development
Note: Buyer depth varies by product type – diagnostic and pharmaceutical companies will find the richest engagement opportunities.
Data sheet
3rd Edition of Infectious Diseases World Conference (IDWC 2026) – Event Attendee & Buyer Profile Analysis
Event Date: 21–23 September 2026
Location: Miami, Florida, USA
Event Status: Upcoming
Research Date: 30 June 2026
Event Overview
| Event Name | 3rd Edition of Infectious Diseases World Conference (IDWC 2026) |
| Event Date | 21–23 September 2026 |
| Event Status | Upcoming |
| Venue | Hilton Garden Inn Miami Dolphin Mall |
| City | Miami |
| State / Region | Florida |
| Country | USA |
| Organizer | Not publicly confirmed in the provided event brief |
| Official Event Website | Not publicly confirmed in the provided event brief |
| Event Type | Medical research and infectious diseases conference focused on clinical practice, epidemiology, public health, diagnostics, antimicrobial resistance, and vaccine-related topics |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness; Business Services |
| Audience Reach | National with international relevance |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low to medium; current-year attendance data not publicly verified in the provided brief |
| Main Purpose of Event | To convene clinicians, researchers, public health leaders, and life sciences stakeholders around infectious disease prevention, treatment, diagnostics, surveillance, and therapeutic innovation |
About the Event
IDWC 2026 is positioned as a specialist infectious diseases forum for medical, scientific, and public health professionals. The conference theme typically centers on disease surveillance, outbreak response, antimicrobial resistance, vaccine development, diagnostics, and evidence-based clinical practice, making it relevant to both healthcare delivery and life sciences innovation.
For B2B prospecting, the event is most valuable because it attracts decision-makers and influencers across hospitals, public health agencies, research institutions, pharmaceutical organizations, diagnostics suppliers, and government-related health stakeholders. This creates strong lead-generation potential for companies selling clinical solutions, laboratory technologies, digital health tools, professional services, training, and research-enabled products.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Clinical leadership | Hospitals, health systems, specialty clinics, infectious disease centers | Influences treatment protocols, product adoption, and pathway design | High-value audience for diagnostics, therapeutics, and clinical decision support |
| Procurement and sourcing teams | Hospitals, labs, public health systems, universities | Purchases equipment, consumables, testing services, and vendor contracts | Direct buying authority for lab, diagnostic, and operational suppliers |
| Public health officials | Federal, state, county, and municipal health departments | Policy, surveillance, preparedness, and program funding influence | Relevant for surveillance, reporting, training, and outbreak-response solutions |
| Research scientists and investigators | Universities, research institutes, biotech firms, clinical trial groups | Selects research tools, assays, reagents, instruments, and services | Important for life sciences suppliers and research vendors |
| Pharma and biotech executives | Pharmaceutical, biotech, vaccine, and diagnostics companies | Budget holders for partnerships, R&D, and commercial initiatives | Strong audience for strategic partnerships and innovation sales |
| Laboratory leadership | Clinical labs, reference labs, academic labs, hospital labs | Influences test menu, platform selection, and operational purchases | Key for diagnostic, automation, and sample processing vendors |
| Medical educators and training directors | Medical schools, residency programs, continuing education providers | Influences curriculum, training platforms, and education partnerships | Relevant for education, content, simulation, and training solutions |
| Government and policy stakeholders | Health ministries, regulators, public health agencies, procurement offices | Policy setting, grant allocation, procurement, and compliance oversight | Strong for vendors serving regulated healthcare and public programs |
| Investors and strategic partners | VC, PE, corporate development, health tech investors | Funding, partnerships, and market expansion decisions | Useful for companies seeking financing, distribution, or commercialization |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Miami | Local hospitals, universities, labs, and health providers | Medium | Strong access to South Florida healthcare and life sciences stakeholders |
| Host state / region: Florida | State health agencies, hospital networks, research institutions | High | Florida is a major healthcare, biotech, and tourism corridor with strong regional participation potential |
| Nearby business hubs | Fort Lauderdale, West Palm Beach, Orlando, Tampa, Jacksonville | Medium to high | Regional hospital systems, lab networks, and medtech buyers are likely sources of attendance |
| National reach | USA-wide clinicians, researchers, procurement leaders, and public health stakeholders | High | Infectious disease conferences often pull nationwide participation because of cross-state clinical and policy relevance |
| International reach | Latin America, Caribbean, Europe, Middle East, Asia-Pacific | Medium | Miami’s international connectivity supports cross-border health and research participation |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The infectious diseases topic has inherently global relevance due to surveillance, outbreaks, antimicrobial resistance, and vaccine development |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Centers for Disease Control and Prevention | Government / public health | Core infectious disease surveillance, prevention, and response stakeholder | cdc.gov | Program Director, Epidemiologist, Procurement Specialist, Public Health Advisor | Strong Market Fit, Attendance Not Confirmed |
| National Institutes of Health | Government / research | Funds and conducts infectious disease research and translational science | nih.gov | Research Program Officer, Grants Manager, Principal Investigator, Lab Director | Strong Market Fit, Attendance Not Confirmed |
| Food and Drug Administration | Government / regulator | Relevant for diagnostics, therapeutics, vaccine, and compliance discussions | fda.gov | Regulatory Affairs Director, Compliance Officer, Medical Officer, Policy Lead | Strong Market Fit, Attendance Not Confirmed |
| Mayo Clinic | Hospital / health system | High-acuity infectious disease care, research, and procurement relevance | mayoclinic.org | Medical Director, Infection Prevention Lead, Procurement Manager, Lab Director | Strong Market Fit, Attendance Not Confirmed |
| Cleveland Clinic | Hospital / health system | Major clinical and research buyer for diagnostics and infection control solutions | clevelandclinic.org | Chief Medical Officer, Director of Infectious Diseases, Sourcing Manager | Strong Market Fit, Attendance Not Confirmed |
| Johns Hopkins Medicine | Academic medical center | World-leading infectious disease research and clinical expertise | hopkinsmedicine.org | Department Chair, Research Director, Clinical Procurement Lead | Strong Market Fit, Attendance Not Confirmed |
| Pfizer | Pharmaceutical | Vaccines, anti-infectives, and clinical partnership relevance | pfizer.com | Medical Affairs Director, R&D Director, Business Development Manager | Strong Market Fit, Attendance Not Confirmed |
| Merck & Co., Inc. | Pharmaceutical | Anti-infectives, vaccine, and global health interest | merck.com | Medical Director, Clinical Development Lead, Alliance Manager | Strong Market Fit, Attendance Not Confirmed |
| GSK | Pharmaceutical | Vaccines and infectious disease therapeutic portfolio alignment | gsk.com | Brand Lead, Medical Affairs, Research Partnerships Director | Strong Market Fit, Attendance Not Confirmed |
| Thermo Fisher Scientific | Life sciences tools / diagnostics | Diagnostic and laboratory technology buyer-relevant ecosystem partner | thermofisher.com | Sales Director, Lab Solutions Manager, Strategic Account Executive | Strong Market Fit, Attendance Not Confirmed |
| Quest Diagnostics | Diagnostics / laboratory services | Clinical testing, infectious disease panels, and lab workflow relevance | questdiagnostics.com | Laboratory Director, Procurement Manager, Business Development Lead | Strong Market Fit, Attendance Not Confirmed |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer / Clinical Director | Clinical leadership | C-level / VP | Drives clinical standards, vendor approval, and pathway adoption |
| 2 | Chief Procurement Officer / VP Procurement | Procurement | C-level / VP | Approves purchasing strategy for high-value clinical and lab solutions |
| 3 | Director of Infectious Diseases / Epidemiology | Medical / public health | Director | Subject-matter owner for clinical and surveillance requirements |
| 4 | Procurement Manager / Sourcing Manager | Supply chain / procurement | Manager | Handles vendor evaluation, RFQs, and contract negotiations |
| 5 | Laboratory Director / Lab Manager | Laboratory operations | Director / Manager | Purchases diagnostic platforms, consumables, and automation |
| 6 | Regulatory Affairs Director / Compliance Officer | Regulatory / compliance | Director / senior manager | Important for product approvals and policy-aligned commercialization |
| 7 | Medical Affairs Director / Scientific Affairs Lead | Medical affairs | Director | Supports evidence generation, education, and KOL engagement |
| 8 | Research Program Officer / PI | Research | Senior / director | Influences research tool adoption, grants, and collaborations |
| 9 | Public Health Director / Epidemiologist | Public health | Director / manager | Influences surveillance, preparedness, and program procurement |
| 10 | Business Development Director / Partnerships Director | Commercial / alliances | Director | Targets partnership, licensing, and commercialization opportunities |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core attendee base for infectious disease care and procurement | Hospital buyers, clinical leaders, infection prevention teams |
| 2 | Pharmaceuticals | Therapeutics, vaccines, and medical affairs relevance | Medical affairs, R&D, commercial partnerships |
| 3 | Biotechnology | Research, diagnostics, and novel therapeutics | R&D, translational science, partnering |
| 4 | Medical Devices | Diagnostics, monitoring, sample handling, and clinical tools | Clinical procurement, lab operations |
| 5 | Medical Practice | Physician groups and specialty care decision-makers | Practice owners, physicians, administrators |
| 6 | Government Administration | Public health, procurement, and policy participants | Agencies, regulators, program managers |
| 7 | Research | Academic and translational infectious disease work | Principal investigators, research administrators |
| 8 | Biotechnology Research | If targeting advanced lab and discovery buyers | Lab technology, assays, platform sales |
| 9 | Information Technology & Services | Clinical informatics and surveillance platforms are often relevant | Data, workflow, interoperability solutions |
| 10 | Environmental Services | Infection control, sanitation, and biohazard management | Facility hygiene, decontamination, waste handling |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Confirmed absence of public figure | Provided event brief does not include a verified current-year attendance count | Use caution when selling attendee lists or lead volumes |
| Exhibitor count | Not publicly confirmed | Unavailable | No official exhibitor directory supplied | Likely a conference-led rather than large trade-show format |
| Buyer count | Not publicly confirmed | Unavailable | No official buyer list supplied | Buyer-side concentration expected from healthcare and public health organizations |
| Speaker count | Not publicly confirmed | Unavailable | No verified agenda provided | Speaker roster would materially improve lead targeting |
| Sponsor count | Not publicly confirmed | Unavailable | No sponsor list supplied | Potential sponsor targets include diagnostics, pharma, and lab tools companies |
| Historical attendance | 4,500+ delegates | Historical / prior-year evidence | Referenced in the provided descriptive brief for a prior edition / alternate listing | Useful only as directional evidence; not verified for Miami 2026 |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Diagnostics | Faster, more accurate detection and testing workflows | Demonstrate clinical performance and turnaround improvements | Assay platforms, lab instruments, sample prep, software |
| Antimicrobial resistance | Stewardship, surveillance, and treatment optimization | Target infection control and stewardship leaders | Decision support, analytics, monitoring tools |
| Vaccines and therapeutics | Clinical evidence, trial support, and development partnerships | Meet pharma and biotech stakeholders around pipeline needs | R&D services, CRO support, trial recruitment, analytics |
| Public health surveillance | Reporting, outbreak monitoring, data integration | Engage agencies and health departments | Dashboards, interoperability, case-tracking tools |
| Infection prevention | Hospital hygiene, decontamination, and safety | Target hospital operations and quality teams | Disinfectants, PPE, monitoring systems, training |
| Medical education | CME, clinical training, and academic content | Connect with educators, societies, and training directors | Education platforms, events, publishing, simulation |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | Attendee mix is likely to include clinical, research, procurement, and public health decision-makers |
| Decision-maker availability | High | The topic attracts senior clinical and scientific roles, plus procurement and partnership stakeholders |
| Data collection potential | Medium | Useful if official agenda, speaker list, or exhibitor directory becomes available |
| Apollo targeting potential | Very High | Clear industry, title, and department segmentation is possible across healthcare, pharma, biotech, and government |
| Geographic targeting potential | High | Miami supports regional U.S. and international outreach, especially Latin America and the Caribbean |
| Best outreach approach | High-touch outbound + research-led personalization | Use role-specific messaging for clinicians, procurement, and public health stakeholders |
| Overall lead quality | High | Strong event for B2B attendee list building in healthcare, diagnostics, and research ecosystems |
| Best use case | Lead generation, exhibitor outreach, speaker outreach, and account-based marketing | Best for suppliers selling to hospitals, labs, pharma, public health, and research organizations |
| Limitations / risks | Moderate | Current-year attendee list and event scale are not publicly verified in the provided brief |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Pharmaceuticals; Biotechnology; Medical Devices; Government Administration; Research; Information Technology & Services; Environmental Services | Focus on buyer-side healthcare, life sciences, and public sector organizations |
| Departments | Procurement; Supply Chain; Clinical Operations; Medical Affairs; Research; Public Health; Regulatory Affairs; Business Development | Reach functions with budget, influence, or implementation authority |
| Seniority | Manager; Director; VP; CXO; Head; Principal; Senior | Prioritize decision-makers and key influencers |
| Job titles | Chief Medical Officer, Director of Infectious Diseases, Procurement Manager, Lab Director, Epidemiologist, Medical Affairs Director, Regulatory Affairs Director, Public Health Director, Research Program Officer, Business Development Director | Create title-based precision lists for outreach and attendee matching |
| Geography | Florida, Southeast USA, Northeast USA, Texas, California, National USA, Caribbean, Latin America | Align with Miami’s regional pull and international health connectivity |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001–10,000; 10,000+ | Covers hospitals, pharma, biotech, labs, and government-adjacent institutions |
| Keywords | infectious disease, epidemiology, antimicrobial resistance, vaccine, diagnostics, laboratory, public health, infection prevention, clinical research, outbreak, surveillance | Refine lists around event theme and buying intent |
| Company type | Hospitals, health systems, laboratories, universities, pharma, biotech, public agencies, diagnostics companies | Focus on organizations most likely to buy or influence purchase decisions |
| Funding / public company filters | Public company; VC-backed biotech; grant-funded research organizations | Helps prioritize firms with budgets and active innovation pipelines |
Suggested Apollo Search Logic: (Hospital & Health Care OR Pharmaceuticals OR Biotechnology OR Medical Devices OR Government Administration OR Research) AND (Procurement OR Supply Chain OR Medical Affairs OR Public Health OR Regulatory Affairs OR Clinical Operations OR Lab Director) AND (infectious disease OR epidemiology OR vaccine OR diagnostics OR antimicrobial resistance OR outbreak OR surveillance)
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| User-provided event brief | Primary input supplied by requester | Event title, Miami location, venue, and 21–23 September 2026 date | Medium |
| Hilton Garden Inn Miami Dolphin Mall | Venue website | Venue identity and location context | High |
| CDC | Official government source | Context for infectious disease surveillance and public health buyer roles | High |
| NIH | Official government source | Context for infectious disease research stakeholders | High |
| FDA | Official government source | Context for regulatory and compliance stakeholders relevant to diagnostics and therapeutics | High |
| Prior-year / alternate edition evidence embedded in requester brief | Historical evidence | Directional attendance context and attendee composition themes only | Low to medium |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 3rd Edition of Infectious Diseases World Conference (IDWC 2026) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds